Dova Pharmaceuticals

Biopharma M&A: deal-depressed third quarter leaves nowhere to hide
Biopharma M&A: deal-depressed third quarter leaves nowhere to hide
EP Vantage
M&A
Lundbeck
Alder Biopharmaceuticals
Gilead Sciences
Galapagos
Vertex Pharmaceuticals
Semma
Swedish Orphan Biovitrum
Dova Pharmaceuticals
Novartis
IFM
Flag link:
Dova Pharma's bet on Eisai castoff spells gold as Sobi spends millions to acquire it
Dova Pharma's bet on Eisai castoff spells gold as Sobi spends millions to acquire it
Endpoints
Dova Pharmaceuticals
Eisai
Swedish Orphan Biovitrum
M&A
Flag link:
3 Small-Cap Biotech Stocks That Soared Last Week
3 Small-Cap Biotech Stocks That Soared Last Week
Motley Fool
Dova Pharmaceuticals
Doptelet
Krystal Biotech
KB103
MeiraGTx
gene therapy
AAV-RPE65
Flag link:
FDA Action Alert: Regeneron, Sanofi, Celgene
FDA Action Alert: Regeneron, Sanofi, Celgene
BioSpace
FDA
drug approvals
Acer Therapeutics
Edsivo
Regeneron
Sanofi
Dupixent
Celgene
Revlimid
Alexion
Soliris
Dova Pharmaceuticals
Doptelet
Nabriva Therapeutics
Contepo
Retrophin
Thiola
Flag link:
Go or no go? Merck, Regeneron and Alexion await US expansion
Go or no go? Merck, Regeneron and Alexion await US expansion
EP Vantage
Merck
Keytruda
Sanofi
Regeneron
Dupixent
Alexion
Soliris
FDA
Dova Pharmaceuticals
Retrophin
Flag link:
Salix arms its GI salesforce with 2nd liver treatment in Doptelet co-promotional deal
Salix arms its GI salesforce with 2nd liver treatment in Doptelet co-promotional deal
Fierce Pharma
Salix
Dova Pharmaceuticals
Doptelet
FDA
chronic liver disease
Flag link:
FDA approves first TPO agonist for chronic liver disease
FDA approves first TPO agonist for chronic liver disease
Biopharma Dive
FDA
Dova Pharmaceuticals
Doptelet
chronic liver disease
thrombocytopenia
Flag link:
Another biotech IPO boasting a pharma castoff rings the bell on Wall Street with $75M haul
Another biotech IPO boasting a pharma castoff rings the bell on Wall Street with $75M haul
Endpoints
IPOs
biotech
Dova Pharmaceuticals
Mersana
Aileron
Flag link: